share_log

10-Q: Q2 2024 Earnings Report

10-Q: Q2 2024 Earnings Report

10-Q:2024財年二季報
美股SEC公告 ·  08/19 08:07
Moomoo AI 已提取核心訊息
FOXO Technologies Inc. (FOXO) reported financial results for the quarter ended June 30, 2024. The company saw an increase in net revenues to $35, up 40% from $25 in the same period last year, primarily due to the acquisition of Myrtle, a behavioral health services provider. Operating expenses decreased by 81% to $2,803, with significant reductions in research and development, management contingent share plan expenses, and selling, general and administrative expenses. The company's net loss improved by 81% to $3,668, compared to a net loss of $18,932 in the prior year. The improvement was attributed to the decrease in operating expenses and non-operating expenses. FOXO's liquidity position remains a concern, with a working capital deficit and total stockholders' deficit of $20,817 and $16,167, respectively. The company has taken steps...Show More
FOXO Technologies Inc. (FOXO) reported financial results for the quarter ended June 30, 2024. The company saw an increase in net revenues to $35, up 40% from $25 in the same period last year, primarily due to the acquisition of Myrtle, a behavioral health services provider. Operating expenses decreased by 81% to $2,803, with significant reductions in research and development, management contingent share plan expenses, and selling, general and administrative expenses. The company's net loss improved by 81% to $3,668, compared to a net loss of $18,932 in the prior year. The improvement was attributed to the decrease in operating expenses and non-operating expenses. FOXO's liquidity position remains a concern, with a working capital deficit and total stockholders' deficit of $20,817 and $16,167, respectively. The company has taken steps to address its capital needs, including entering into stock exchange agreements with RHI to acquire Myrtle and RCHI, a critical care hospital, which are expected to provide positive operating cash flows. However, there is substantial doubt about FOXO's ability to continue as a going concern without securing additional financing. The company's future plans include continuing capital raise initiatives, pursuing strategic acquisitions, and commercializing products to generate revenue.
FOXO技術公司(FOXO)公佈了2024年6月30日結束的季度財務報告。該公司的淨收入上升至35美元,比去年同期的25美元增長了40%,這主要是由於收購了行爲健康服務提供商Myrtle而導致的。營業費用下降了81%至2,803美元,研發、管理和銷售一般管理費用大幅減少。淨虧損從上年的18,932美元減少了81%至3,668美元。這一改善歸因於營業費用和非營業費用的減少。FOXO的流動性仍然是一個問題,其營運資本虧損和總股東虧損分別爲20,817美元和16,167美元。公司已經採取了措施來解決其資本需求,包括與RHI訂立股票交易協議以收購Myrtle和一家關鍵護理醫院RCHI,預計將提供正面的營運現金流。然而,FOXO能否在未獲得額外融資的情況下繼續作爲一個持續發展的公司存在存在重大疑慮。該公司未來的計劃包括繼續資本籌集舉措,追求戰略性收購,並推廣產品以產生收入。
FOXO技術公司(FOXO)公佈了2024年6月30日結束的季度財務報告。該公司的淨收入上升至35美元,比去年同期的25美元增長了40%,這主要是由於收購了行爲健康服務提供商Myrtle而導致的。營業費用下降了81%至2,803美元,研發、管理和銷售一般管理費用大幅減少。淨虧損從上年的18,932美元減少了81%至3,668美元。這一改善歸因於營業費用和非營業費用的減少。FOXO的流動性仍然是一個問題,其營運資本虧損和總股東虧損分別爲20,817美元和16,167美元。公司已經採取了措施來解決其資本需求,包括與RHI訂立股票交易協議以收購Myrtle和一家關鍵護理醫院RCHI,預計將提供正面的營運現金流。然而,FOXO能否在未獲得額外融資的情況下繼續作爲一個持續發展的公司存在存在重大疑慮。該公司未來的計劃包括繼續資本籌集舉措,追求戰略性收購,並推廣產品以產生收入。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息